Evaluation of Atherosclerotic Risk by Oxidative Contributors in Alcohol Use Disorder
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objective: Alcohol Use Disorder (AUD) is a condition described as the inability to control or stop alcohol consumption. The patients with AUD have an increased risk of developing atherosclerosis-related diseases. The present study aimed to evaluate oxidative contributors of atherosclerotic risk factors in patients with AUD. Methods: The male subjects diagnosed with AUD (n = 45) and the male subjects as control (n = 35) were enrolled in this study. All participants were undergone psychiatric evaluation and sociodemographic tests. Also, serum oxidative contributors of atherosclerosis including myeloperoxidase (MPO), ferroxidase, catalase (CAT), and lipid hydroperoxides (LOOH) were measured. Additionally, serum lipid profile tests and atherogenic indicators including atherogenic index of plasma (AIP) and non-high-density lipoprotein (HDL) cholesterol were also analyzed. Results: The AUD subject had significantly elevated MPO activity and LOOH levels with decreased antioxidant capacity. AIP and non-HDL cholesterol levels, the atherogenic indicators, were also higher in AUD group compared to the control group. We found the MPO activity and LOOH levels were positively correlated with AIP, non-HDL cholesterol levels, and amount of alcohol consumption. Additionally, CAT activity was negatively correlated with duration of alcohol consumption. Conclusion: Our results revealed that MPO and LOOH levels were elevated by severe alcohol intake and the atherogenic indicators, AIP and non-HDL cholesterol, were significantly correlated alcohol induced elevated oxidative risk factors. Therefore, it can be suggested that MPO activity and LOOH levels may be useful to determine jeopardy of atherosclerotic and the therapeutic interventions that reduce oxidative load could be taken into account to prevent atherosclerotic diseases before clinical manifestation.
Abstract
Objective: Alcohol Use Disorder (AUD) is a condition described as the inability to control or stop alcohol consumption. The patients with AUD have an increased risk of developing atherosclerosis-related diseases. The present study aimed to evaluate oxidative contributors of atherosclerotic risk factors in patients with AUD. Methods: The male subjects diagnosed with AUD (n = 45) and the male subjects as control (n = 35) were enrolled in this study. All participants were undergone psychiatric evaluation and sociodemographic tests. Also, serum oxidative contributors of atherosclerosis including myeloperoxidase (MPO), ferroxidase, catalase (CAT), and lipid hydroperoxides (LOOH) were measured. Additionally, serum lipid profile tests and atherogenic indicators including atherogenic index of plasma (AIP) and non-high-density lipoprotein (HDL) cholesterol were also analyzed. Results: The AUD subject had significantly elevated MPO activity and LOOH levels with decreased antioxidant capacity. AIP and non-HDL cholesterol levels, the atherogenic indicators, were also higher in AUD group compared to the control group. We found the MPO activity and LOOH levels were positively correlated with AIP, non-HDL cholesterol levels, and amount of alcohol consumption. Additionally, CAT activity was negatively correlated with duration of alcohol consumption. Conclusion: Our results revealed that MPO and LOOH levels were elevated by severe alcohol intake and the atherogenic indicators, AIP and non-HDL cholesterol, were significantly correlated alcohol induced elevated oxidative risk factors. Therefore, it can be suggested that MPO activity and LOOH levels may be useful to determine jeopardy of atherosclerotic and the therapeutic interventions that reduce oxidative load could be taken into account to prevent atherosclerotic diseases before clinical manifestation.
참고문헌 (30)
- Flores-Bonilla A, "Sex differences in the neurobiology of alcohol use disorder", Alcohol Res, 40, pp.04~ (2020)
- Minzer S, "The effect of alcohol on cardiovascular risk factors : Is there new information?", Nutrients, 12, pp.912~ (2020)
- Bharath Holla, "Brain Functional Magnetic Resonance Imaging Cue-reactivity Can Predict Baclofen Response in Alcohol Use Disorders", Clinical Psychopharmacology and Neuroscience, 16(3), pp.290~301 (2018), 대한정신약물학회[DOI]
- Stătescu C, "Consensus and controversy in the debate over the biphasic impact of alcohol consumption on the cardiovascular system", Nutrients, 13, pp.1076~ (2021)
- Hao G, "Relationship between alcohol consumption and serum lipid profiles among middle-aged population in China : A multiple-center cardiovascular epidemiological study", Angiology, 66, pp.753~758 (2015)
- Khosravi M, "The effects of oxidative stress on the development of atherosclerosis", Biol Chem, 400, pp.711~732 (2019)
- Sogut I, "Thiol", disulfide homeostasis and oxidant status in children with congenital heart disease, 2022, pp.47, 257~265
- Chen X, "Ferroptosis and cardiovascular disease : Role of free radical-induced lipid peroxidation", Free Radic Res, 55, pp.405~415 (2021)
- Gibbs LE, "Validity and reliability of the Michigan alcoholism screening test : A review", Drug Alcohol Depend, 12, pp.279~285 (1983)
- Coskunol H, "Michigan alkolizm tarama testinin geçerliliği", Ege J Med, 34, pp.15~18 (1995)
- World Health Organization, "Brief intervention for hazardous and harmful drinking : A manual for use in primary care", World Health Organization, ~ (2001)
- Bradley PP, "Cellular and extracellular myeloperoxidase in pyogenic inflammation", Blood, 60, pp.618~622 (1982)
- Siotto M, "Automation of o-dianisidine assay for ceruloplasmin activity analyses: Usefulness of investigation in Wilson's disease and in hepatic encephalopathy", J Neural Transm(Vienna), 121, pp.1281~1286 (2014)
- Góth L, "A simple method for determination of serum catalase activity and revision of reference range", Clin Chim Acta, 196, pp.143~151 (1991)
- Nourooz-Zadeh J, "Ferrous ion oxidation in presence of xylenol orange for detection of lipid hydroperoxides in plasma", Methods Enzymol, 300, pp.58~62 (1999)
- Li YW, "Atherogenic index of plasma as predictors for metabolic syndrome, hypertension and diabetes mellitus in Taiwan citizens : A 9-year longitudinal study", Sci Rep, 11, pp.9900~ (2021)
- Afsin A, "Plasma atherogenic indices are independent predictors of slow coronary flow", BMC Cardiovasc Disord, 21, pp.608~ (2021)
- Klop B, "Alcohol and plasma triglycerides", Curr Opin Lipidol, 24, pp.321~326 (2013)
- You M, "Effect of ethanol on lipid metabolism", J Hepatol, 70, pp.237~248 (2019)
- Frangie C, "Role of myeloperoxidase in inflammation and atherosclerosis(Review)", Biomed Rep, 16, pp.53~ (2022)
- Eren E, "High density lipoprotein and it's dysfunction", Open Biochem J, 6, pp.78~93 (2012)
- Ramachandra CJA, "Myeloperoxidase as a multifaceted target for cardiovascular protection", Antioxid Redox Signal, 32, pp.1135~1149 (2020)
- Zhang Y, "Prognostic value of the expression of DNA repair-related biomarkers mediated by alcohol in gastric cancer patients", Am J Pathol, 188, pp.367~377 (2018)
- Giovannini S, "Myeloperoxidase levels and mortality in frail community-living elderly individuals", J Gerontol A Biol Sci Med Sci, 65, pp.369~376 (2010)
- Arnhold J, "The dual role of myeloperoxidase in immune response", Int J Mol Sci, 21, pp.8057~ (2020)
- Asano M, "Lipid hydroperoxides in human plasma after ethanol consumption", Leg Med (Tokyo), 11(Suppl 1), pp.S223~S225 (2009)
- Salehi E, "Curcumin can be acts as effective agent for prevent or treatment of alcohol-induced toxicity in hepatocytes : An illustrated mechanistic review", Iran J Pharm Res, 20, pp.418~436 (2021)
- Tan HK, "Oxidative stress in alcohol-related liver disease", World J Hepatol, 12, pp.332~349 (2020)
- Janani AV, "Antioxidant vitamins and enzymes status in patients with alcoholic liver disease", J Clin Diagn Res, 4, pp.2742~2747 (2010)
- Das KS, "Evaluation of blood oxidative stress-related parameters in alcoholic liver disease and non-alcoholic fatty liver disease", Scand J Clin Lab Invest, 68, pp.323~334 (2008)